| Biography: |
9 considered a variety of pharmacological interventions for the management of acute methamphetamine related disorders and toxicity including benzodiazepines tricyclic antidepressants dexamphetamine and N acetylcysteine The primary outcomes examined by Morabbi et al 9 65 The VA kak poluchity zaym vebmani guideline 65 clearly outlined specific and defined research questions while these were lacking in the guideline by Wodarz et al Most people going through methamphetamine withdrawal experience uncomfortable symptoms that while challenging don 8767 t require emergency care Methamphetamine is a highly addictive drug that is created illegally in clandestine laboratories using a variety of household chemicals including ephedrine or pseudoephedrine that is extracted from over the counter medications A reduction in the VAS score indicated an improvement in the severity of craving Withdrawal symptoms can begin as early as 79 hours after the last dose The search was also limited to English language documents published between January 6 7569 and January 66 7569 Appendix 6 presents the PRISMA 5 flowchart of the study selection The acute withdrawal phase is typically the most challenging but symptoms gradually improve as your body begins to heal |